Latent and lytic Epstein-Barr virus replication strategies

Reviews in Medical Virology
Tatsuya TsurumiAyumi Kudoh

Abstract

The Epstein-Barr virus (EBV) can choose between two alternative lifestyles; latent or lytic replication. In the latent state, the EBV genomic DNA, which exists as a closed circular plasmid, appears to behave just like host chromosomal DNA and it has been demonstrated recently that replication of OriP-containing plasmids is indeed dependent on the chromosomal initiation factors, ORC2 and Cdt1. On the other hand, in the viral productive cycle, the EBV genome is amplified 100- to 1000-fold by the viral replication machinery. EBV productive DNA replication occurs at discrete sites in nuclei, called replication compartments and the lytic programme arrests cell cycle progression and changes the cellular environment greatly. It has been revealed recently that the EBV lytic programme promotes an S-phase like cellular condition, which most favours viral lytic replication. This review describes recent advances regarding the molecular basis of EBV DNA replication during latent and lytic infections and then refers to cellular circumstances after induction of the lytic replication of EBV. Based on the molecular mechanism for the EBV lifestyle, purposeful induction of the lytic form of EBV infection is now advocated as one of the strategies ...Continue Reading

References

Mar 1, 1991·Molecular and Cellular Biology·P J Krysan, M P Calos
May 1, 1990·Journal of Virology·G PackhamP J Farrell
Mar 1, 1989·Molecular and Cellular Biology·P J KrysanM P Calos
Sep 1, 1985·The Journal of General Virology·P J Dyson, P J Farrell
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·J YatesB Sugden
Apr 1, 1995·Seminars in Cancer Biology·P D Adams, W G Kaelin
Feb 1, 1995·Journal of Virology·A L Kirchmaier, B Sugden
Apr 1, 1994·Molecular and Cellular Biology·H ZhangA Bradley
Feb 4, 1994·Science·W C Burhans, J A Huberman
Nov 1, 1993·Molecular Biology of the Cell·H MasukataT Okazaki
Sep 23, 1997·Biochemical and Biophysical Research Communications·T TsurumiY Nishiyama
Mar 21, 1998·Journal of Biochemistry·M Shirakata, K Hirai
Jul 10, 1999·Journal of Virology·J J SwensonS C Kenney
Nov 30, 1999·Frontiers in Bioscience : a Journal and Virtual Library·M Fujita

❮ Previous
Next ❯

Citations

Oct 6, 2009·The Journal of Biological Chemistry·Kazutaka MurayamaShigeyuki Yokoyama
Apr 29, 2011·The Journal of Biological Chemistry·Takayuki MurataTatsuya Tsurumi
Aug 13, 2013·The Journal of Infectious Diseases·Seigo UedaDavid Nadal
May 5, 2007·Nucleic Acids Research·Shao-An Xue, Beverly E Griffin
Jan 15, 2011·Clinical Microbiology Reviews·Oludare A OdumadeHenry H Balfour
Nov 25, 2005·Journal of Virology·Toomas SillaMart Ustav
Jan 5, 2011·Infectious Agents and Cancer·Julie L RyanMargaret L Gulley
Mar 25, 2011·Herpesviridae·Rhiannon R Penkert, Robert F Kalejta
Nov 6, 2008·Veterinary Pathology·A K Marr-BelvinS V Westmoreland
Apr 30, 2011·Future Microbiology·Renfeng Li, S Diane Hayward
Sep 26, 2013·Clinical & Developmental Immunology·Anette Holck DraborgGunnar Houen
Jul 20, 2012·Clinical & Developmental Immunology·Anette Holck DraborgGunnar Houen
May 6, 2014·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Nina Mikirova, Ronald Hunninghake
Nov 3, 2015·Reviews in Medical Virology·Sigvard OlofssonHans H Wandall
Jun 10, 2015·Virology·Takahiro WatanabeTakayuki Murata
Nov 29, 2007·Trends in Immunology·Becca Asquith, Charles R M Bangham
Jul 28, 2011·International Journal of Cancer. Journal International Du Cancer·Guo-Ping ShenWei-Hua Jia
Nov 12, 2010·Journal of Cellular Biochemistry·Raquel T LimaM Helena Vasconcelos
May 3, 2014·Microbiology and Immunology·Takayuki Murata
Dec 11, 2013·Periodontology 2000·Adolfo ContrerasJørgen Slots
Mar 1, 2014·Reviews in Medical Virology·Takayuki MurataHiroshi Kimura
Dec 18, 2013·Reviews in Medical Virology·Takayuki Murata, Tatsuya Tsurumi

❮ Previous
Next ❯

Related Concepts

Related Feeds